Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Weinberg

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Circulation|May 18, 2005
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growthRudolf Kirchmair, Dirk H Walter, Masaaki Ii, et al.
European Journal of Pharmacology|May 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesityDouglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
European Journal of Pharmacology|August 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesityDouglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonistsRaman K Bakshi, Qingmei Hong, J T Olson, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonistsLiangqin Guo, Zhixiong Ye, Jian Liu, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonistQingmei Hong, Raman K Bakshi, Brenda L Palucki, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonistBrenda L Palucki, Min K Park, Ravi P Nargund, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Circulation|May 18, 2005
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growthRudolf Kirchmair, Dirk H Walter, Masaaki Ii, et al.
European Journal of Pharmacology|May 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesityDouglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
European Journal of Pharmacology|August 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesityDouglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonistsRaman K Bakshi, Qingmei Hong, J T Olson, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonistsLiangqin Guo, Zhixiong Ye, Jian Liu, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonistQingmei Hong, Raman K Bakshi, Brenda L Palucki, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonistBrenda L Palucki, Min K Park, Ravi P Nargund, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Pageof 4